Skip to main content
Clinical Trials/ISRCTN98243550
ISRCTN98243550
Completed
未知

Towards a patient supported, well tolerated and evidence based prophylactic swallowing exercise program to improve quality of life and swallowing function in head and neck cancer patients treated with chemoradiotherapy: a multicentre randomized controlled trial

Antwerp University Hopsital0 sites150 target enrollmentDecember 21, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Head and neck cancer treated with radiotherapy or concomitant chemoradiotherapy
Sponsor
Antwerp University Hopsital
Enrollment
150
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/32122397 protocol (added 04/03/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36121560/ (added 20/09/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37550571/ Effect of service-delivery mode and overall adherence level (added 09/08/2023)

Registry
who.int
Start Date
December 21, 2018
End Date
June 30, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Antwerp University Hopsital

Eligibility Criteria

Inclusion Criteria

  • 1\. Newly diagnosed squamous cell carcinoma of the oropharynx
  • 2\. Stage III or IV cancer (according to TNM\-7 classification)
  • 3\. Treatment with radiotherapy or concomitant chemoradiotherapy with/without induction chemotherapy
  • 4\. Demonstrating sufficient cognitive and language abilities

Exclusion Criteria

  • 1\. Recurrent carcinoma or metastasis from a non\-HNC (head and neck cancer) carcinoma
  • 2\. Previous radiotherapy and/or chemoradiotherapy ,or surgery in head\-neck region with possible impact on swallowing function

Outcomes

Primary Outcomes

Not specified

Similar Trials